| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $16.5M | +94.8% |
| SG&A Expense | $9.0M | +48.5% |
| Operating Income | -$25.5M | -75.5% |
| Pre-tax Income | -$25.3M | -74.8% |
| Net Income | -$25.3M | -74.8% |
| EPS (Basic) | -$3.10 | -63.2% |
| EPS (Diluted) | -$3.10 | -63.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.4M | -37.9% |
| Current Assets | $36.0M | -21.7% |
| Total Assets | $36.0M | -21.7% |
| Current Liabilities | $7.7M | +411.0% |
| Total Liabilities | $7.7M | +411.0% |
| Stockholders' Equity | $28.3M | -36.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.3M | -89.6% |
| Financing Cash Flow | $5K | -100.0% |